Tobacco and nicotine product testing

Dorothy K. Hatsukami, Lois Biener, Scott J. Leischow, Mitch R. Zeller

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Introduction: Tobacco product testing is a critical component of the Family Smoking Prevention and Tobacco Control Act (FSPTCA), which grants the Food and Drug Administration the authority to regulate tobacco products. The availability of methods and measures that can provide accurate data on the relative health risks across types of tobacco products, brands, and subbrands of tobacco products on the validity of any health claims associated with a product, and on how consumers perceive information on products toxicity or risks is crucial for making decisions on the product's potential impact on public health. These tools are also necessary for making assessments of the impact of new indications for medicinal products (other than cessation) but more importantly of tobacco products that may in the future be marketed as cessation tools. Objective: To identify research opportunities to develop empirically based and comprehensive methods and measures for testing tobacco and other nicotine-containing products so that the best science is available when decisions are made about products or policies. Methods: Literature was reviewed to address sections of the FSPTCA relevant to tobacco product evaluation; research questions were generated and then reviewed by a committee of research experts. Results: A research agenda was developed for tobacco product evaluation in the general areas of toxicity and health risks, abuse liability, consumer perception, and population effects. Conclusion: A cohesive, systematic, and comprehensive assessment of tobacco products is important and will require building consensus and addressing some crucial research questions.

Original languageEnglish (US)
Article numberntr027
Pages (from-to)7-17
Number of pages11
JournalNicotine and Tobacco Research
Volume14
Issue number1
DOIs
StatePublished - 2012
Externally publishedYes

Fingerprint

Nicotine
Tobacco Products
Research
Health
Smoking
Organized Financing
United States Food and Drug Administration
Tobacco
Consensus
Decision Making
Public Health
Population

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Hatsukami, D. K., Biener, L., Leischow, S. J., & Zeller, M. R. (2012). Tobacco and nicotine product testing. Nicotine and Tobacco Research, 14(1), 7-17. [ntr027]. https://doi.org/10.1093/ntr/ntr027

Tobacco and nicotine product testing. / Hatsukami, Dorothy K.; Biener, Lois; Leischow, Scott J.; Zeller, Mitch R.

In: Nicotine and Tobacco Research, Vol. 14, No. 1, ntr027, 2012, p. 7-17.

Research output: Contribution to journalArticle

Hatsukami, DK, Biener, L, Leischow, SJ & Zeller, MR 2012, 'Tobacco and nicotine product testing', Nicotine and Tobacco Research, vol. 14, no. 1, ntr027, pp. 7-17. https://doi.org/10.1093/ntr/ntr027
Hatsukami DK, Biener L, Leischow SJ, Zeller MR. Tobacco and nicotine product testing. Nicotine and Tobacco Research. 2012;14(1):7-17. ntr027. https://doi.org/10.1093/ntr/ntr027
Hatsukami, Dorothy K. ; Biener, Lois ; Leischow, Scott J. ; Zeller, Mitch R. / Tobacco and nicotine product testing. In: Nicotine and Tobacco Research. 2012 ; Vol. 14, No. 1. pp. 7-17.
@article{87580958e0154e6bbccfdb80fc74f260,
title = "Tobacco and nicotine product testing",
abstract = "Introduction: Tobacco product testing is a critical component of the Family Smoking Prevention and Tobacco Control Act (FSPTCA), which grants the Food and Drug Administration the authority to regulate tobacco products. The availability of methods and measures that can provide accurate data on the relative health risks across types of tobacco products, brands, and subbrands of tobacco products on the validity of any health claims associated with a product, and on how consumers perceive information on products toxicity or risks is crucial for making decisions on the product's potential impact on public health. These tools are also necessary for making assessments of the impact of new indications for medicinal products (other than cessation) but more importantly of tobacco products that may in the future be marketed as cessation tools. Objective: To identify research opportunities to develop empirically based and comprehensive methods and measures for testing tobacco and other nicotine-containing products so that the best science is available when decisions are made about products or policies. Methods: Literature was reviewed to address sections of the FSPTCA relevant to tobacco product evaluation; research questions were generated and then reviewed by a committee of research experts. Results: A research agenda was developed for tobacco product evaluation in the general areas of toxicity and health risks, abuse liability, consumer perception, and population effects. Conclusion: A cohesive, systematic, and comprehensive assessment of tobacco products is important and will require building consensus and addressing some crucial research questions.",
author = "Hatsukami, {Dorothy K.} and Lois Biener and Leischow, {Scott J.} and Zeller, {Mitch R.}",
year = "2012",
doi = "10.1093/ntr/ntr027",
language = "English (US)",
volume = "14",
pages = "7--17",
journal = "Nicotine and Tobacco Research",
issn = "1462-2203",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Tobacco and nicotine product testing

AU - Hatsukami, Dorothy K.

AU - Biener, Lois

AU - Leischow, Scott J.

AU - Zeller, Mitch R.

PY - 2012

Y1 - 2012

N2 - Introduction: Tobacco product testing is a critical component of the Family Smoking Prevention and Tobacco Control Act (FSPTCA), which grants the Food and Drug Administration the authority to regulate tobacco products. The availability of methods and measures that can provide accurate data on the relative health risks across types of tobacco products, brands, and subbrands of tobacco products on the validity of any health claims associated with a product, and on how consumers perceive information on products toxicity or risks is crucial for making decisions on the product's potential impact on public health. These tools are also necessary for making assessments of the impact of new indications for medicinal products (other than cessation) but more importantly of tobacco products that may in the future be marketed as cessation tools. Objective: To identify research opportunities to develop empirically based and comprehensive methods and measures for testing tobacco and other nicotine-containing products so that the best science is available when decisions are made about products or policies. Methods: Literature was reviewed to address sections of the FSPTCA relevant to tobacco product evaluation; research questions were generated and then reviewed by a committee of research experts. Results: A research agenda was developed for tobacco product evaluation in the general areas of toxicity and health risks, abuse liability, consumer perception, and population effects. Conclusion: A cohesive, systematic, and comprehensive assessment of tobacco products is important and will require building consensus and addressing some crucial research questions.

AB - Introduction: Tobacco product testing is a critical component of the Family Smoking Prevention and Tobacco Control Act (FSPTCA), which grants the Food and Drug Administration the authority to regulate tobacco products. The availability of methods and measures that can provide accurate data on the relative health risks across types of tobacco products, brands, and subbrands of tobacco products on the validity of any health claims associated with a product, and on how consumers perceive information on products toxicity or risks is crucial for making decisions on the product's potential impact on public health. These tools are also necessary for making assessments of the impact of new indications for medicinal products (other than cessation) but more importantly of tobacco products that may in the future be marketed as cessation tools. Objective: To identify research opportunities to develop empirically based and comprehensive methods and measures for testing tobacco and other nicotine-containing products so that the best science is available when decisions are made about products or policies. Methods: Literature was reviewed to address sections of the FSPTCA relevant to tobacco product evaluation; research questions were generated and then reviewed by a committee of research experts. Results: A research agenda was developed for tobacco product evaluation in the general areas of toxicity and health risks, abuse liability, consumer perception, and population effects. Conclusion: A cohesive, systematic, and comprehensive assessment of tobacco products is important and will require building consensus and addressing some crucial research questions.

UR - http://www.scopus.com/inward/record.url?scp=84855167133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855167133&partnerID=8YFLogxK

U2 - 10.1093/ntr/ntr027

DO - 10.1093/ntr/ntr027

M3 - Article

C2 - 21460383

AN - SCOPUS:84855167133

VL - 14

SP - 7

EP - 17

JO - Nicotine and Tobacco Research

JF - Nicotine and Tobacco Research

SN - 1462-2203

IS - 1

M1 - ntr027

ER -